A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In response to tenacious stress signals, such as the unscheduled activation of oncogenes, cells can mobilize tumour suppressor networks to avert the hazard of malignant transformation. A large body of evidence indicates that oncogene-induced senescence (OIS) acts as such a break, withdrawing cells from the proliferative pool almost irreversibly, thus crafting a vital pathophysiological mechanism that protects against cancer. Despite the widespread contribution of OIS to the cessation of tumorigenic expansion in animal models and humans, we have only just begun to define the underlying mechanism and identify key players. Although deregulation of metabolism is intimately linked to the proliferative capacity of cells, and senescent cells are thought to remain metabolically active, little has been investigated in detail about the role of cellular metabolism in OIS. Here we show, by metabolic profiling and functional perturbations, that the mitochondrial gatekeeper pyruvate dehydrogenase (PDH) is a crucial mediator of senescence induced by BRAF(V600E), an oncogene commonly mutated in melanoma and other cancers. BRAF(V600E)-induced senescence was accompanied by simultaneous suppression of the PDH-inhibitory enzyme pyruvate dehydrogenase kinase 1 (PDK1) and induction of the PDH-activating enzyme pyruvate dehydrogenase phosphatase 2 (PDP2). The resulting combined activation of PDH enhanced the use of pyruvate in the tricarboxylic acid cycle, causing increased respiration and redox st…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mitochondria in senescentcellsarelessfunctional,showingdecreasedmembrane potential, increased proton leak, reduced fusion and fission rates, increased mass, and abundance of tricarboxylic acid (TCA) cycle metabolites (Kaplon et al., 2013; Passos et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kaplon et al., 2013
In the citing paper
“Senescent cells exhibit several changes in mitochondrial function, dynamics, and morphology.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kaplon et al., 2013
In the citing paper
“Targeting aspects of mitochondrial biology, such as the electron transport chain (ETC), complex I assembly, mitochondrial fission rates, and biogenesis, mitochondrial sirtuins and/or disruption of the TCA cycle can trigger senescence (Correia-Melo et al., 2016; Jiang et al., 2013; Kaplon et al., 2013; Miwa et al., 2014; Moiseeva et al., 2009; Park et al., 2010; Wiley et al., 2016).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kaplon et al., 2013
In the citing paper
“In addition to the active protein metabolism described above, recent reports have shown that mitochondrial oxidative metabolism is up-regulated in senescent cells to support the metabolic demands of these cells (Dörr et al. 2013; Kaplon et al. 2013).”
From Cellular senescence and its effector programs (2014) · cites this paper as Kaplon et al. 2013
In the citing paper
“This revealed that pyruvate dehydrogenase (PDH) plays a key role in OIS.”
From Cellular senescence and its effector programs (2014) · cites this paper as Kaplon et al. 2013
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Self-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Self-citationThe essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Self-citationFantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
Tsai, J., Lee, J. T., Wang, W., Zhang, J., Cho, H., Mamo, S., Bremer, R., Gillette, S., Kong, J., Haass, N. K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711741105 · Cited by 1,346
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
BrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
Cited by
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150
“OIS has a tumor-suppressive cellular function and a recent study has reported that increased glucose oxidation through pyruvate dehydrogenase (PDH) can regulate OIS.”
BackgroundCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
“Mitochondria in senescentcellsarelessfunctional,showingdecreasedmembrane potential, increased proton leak, reduced fusion and fission rates, increased mass, and abundance of tricarboxylic acid (TCA) cycle metabolites (Kaplon et al., 2013; Passos et al., 2010).”
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
“Indeed, high TCA cycle activity is essential for the tumor-suppressing action of senescent cells [93].”
The mitochondrial basis of aging
Sun, N., Youle, R. J., & Finkel, T. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.01.028 · Cited by 1,441
The hallmarks of cancer metabolism: still emerging
Pavlova, N. N., Zhu, J., & Thompson, C. B. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.007 · Cited by 1,418
Mitochondrial metabolism and cancer
Porporato, P. E., Filigheddu, N., Pedro, J. M. B.-S., Kroemer, G., & Galluzzi, L. (2018) · Cell Research · doi:10.1038/cr.2017.155 · Cited by 1,273
“(PDK1) or inhibit pyruvate dehydrogenase phosphatase catalytic subunit 2 (PDP2), resulting in limited pyruvate utilization by mitochondria and reduced ROS production [59].”
BackgroundCellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“Growing literature on the metabolism of cellular senescence reports that both glucose consumption and lactate production are elevated during senescence (57, 101, 179).”
BackgroundMechanisms and functions of cellular senescence
Herranz, N., & Gil, J. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95148 · Cited by 1,232
“In work related to this concept, Kaplon and colleagues (118) argued that senescent cells must reprogram metabolism in order to support their metabolic demands.”
P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4007 · Cited by 1,080
Metabolic requirements for the maintenance of self-renewing stem cells
Ito, K., & Suda, T. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3772 · Cited by 1,014
Senescence and apoptosis: dueling or complementary cell fates?
Childs, B. G., Baker, D. J., Kirkland, J. L., Campisi, J., & van Deursen, J. M. (2014) · The EMBO Reports · doi:10.15252/embr.201439245 · Cited by 915
“For example, is pyruvate dehydrogenase suppressed in replicative senescence or PTEN-loss-induced senescence [18]? Regardless of differences in signaling pathways, Ras overexpression, BRAF mutation, and Pten deletion ultimately activate common effectors of senescence such as p19 and p16 [22].”
Farge, T., Saland, E., de Toni, F., Aroua, N., Hosseini, M., Perry, R., Bosc, C., Sugita, M., Stuani, L., Fraisse, M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0441 · Cited by 912
Cellular senescence and its effector programs
Salama, R., Sadaie, M., Hoare, M., & Narita, M. (2014) · Genes & Development · doi:10.1101/gad.235184.113 · Cited by 855
“Although, the Peeper and Gottlieb groups (Kaplon et al. 2013) did not report the actual levels of ATP production in OIS cells, another recent study by Dörr et al. (2013) has shown an increase of ATP production in both TIS lymphomas and OIS HDFs.”
BackgroundResultInfluentialMetabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2022) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 770
“The role of PDC in cancer progression remains inconclusive (Kim et al., 2006; Papandreou et al., 2006; Hitosugi et al., 2011; Kaplon et al., 2013; Sutendra et al., 2014).”
BackgroundMitochondria are required for pro-ageing features of the senescent phenotype
Correia‐Melo, C., Marques, F. D., Anderson, R., Hewitt, G., Hewitt, R., Cole, J., Carroll, B. M., Miwa, S., Birch, J., Merz, A., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201592862 · Cited by 796
“However, other reports have also highlighted the importance of non-mitochondrial ROS sources (Takahashi et al , 2006), redox stress (Kaplon et al , 2013) or deficits in antioxidant defence (Blander et al , 2003) in the development of senescence.”
Senescence and cancer — role and therapeutic opportunities
Schmitt, C. A., Wang, B., & Demaria, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00668-4 · Cited by 794
Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease
Smith, R. L., Soeters, M. R., Wüst, R. C. I., & Houtkooper, R. H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00211 · Cited by 787
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
Gerriets, V. A., Kishton, R. J., Nichols, A. G., Macintyre, A. N., Inoue, M., Ilkayeva, O., Winter, P. S., Liu, X., Priyadharshini, B., Slawinska, M. E., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76012 · Cited by 731
Hypoxia and Metabolic Adaptation of Cancer Cells
Eales, K. L., Hollinshead, K. E. R., & Tennant, D. A. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.50 · Cited by 724
The pyruvate dehydrogenase complexes: structure-based function and regulation
Patel, M. S., Nemeria, N. S., Furey, W., & Jordan, F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.563148 · Cited by 674
The dynamic nature of senescence in cancer
Lee, S., & Schmitt, C. A. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0249-2 · Cited by 588
Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis
Xie, N., Tan, Z., Banerjee, S., Cui, H., Ge, J., Liu, R.-M., Bernard, K., Thannickal, V. J., & Liu, G. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0780oc · Cited by 582
Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics
Akaike, T., Ida, T., Wei, F.-Y., Nishida, M., Kumagai, Y., Alam, M. M., Ihara, H., Sawa, T., Matsunaga, T., Kasamatsu, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01311-y · Cited by 544
Caro-Maldonado, A., Wang, R., Nichols, A. G., Kuraoka, M., Milasta, S., Sun, L. D., Gavin, A. L., Abel, E. D., Kelsoe, G., Green, D. R., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302062 · Cited by 549
“DCA nevertheless suppressed glycolytic flux to reduce the ability of lactate dehydrogenase to recycle NAD, thus potentially increasing reactive oxygen species production (44).”
BackgroundIncreased demand for NAD(+) relative to ATP drives aerobic glycolysis
Luengo, A., Li, Z., Gui, D. Y., Sullivan, L. B., Zagorulya, M., Do, B. T., Ferreira, R., Naamati, A., Ali, A., Lewis, C. A., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.12.012 · Cited by 547
Li, X., Jiang, Y., Meisenhelder, J., Yang, W., Hawke, D. H., Zheng, Y., Xia, Y., Aldape, K., He, J., Hunter, T., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.009 · Cited by 508
“We next analyzed 50 human primary GBM specimens with specificity-validated antibodies (Figures S7A and S7B) (Kaplon et al., 2013).”
BackgroundLoo, T. M., Kamachi, F., Watanabe, Y., Yoshimoto, S., Kanda, H., Arai, Y., Nakajima-Takagi, Y., Iwama, A., Koga, T., Sugimoto, Y., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0932 · Cited by 478
Inside and out: the activities of senescence in cancer
Pérez-Mancera, P. A., Young, A. R. J., & Narita, M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3773 · Cited by 462
From Ancient Pathways to Aging Cells—Connecting Metabolism and Cellular Senescence
Wiley, C. D., & Campisi, J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.010 · Cited by 440
“dehydrogenase (PDH), which catalyzes the formation of acetylCoA from pyruvate; this decision determines whether a cell senesces in response to activated oncogenes (Kaplon et al., 2013).”
BackgroundIntercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells
Saha, T., Dash, C., Jayabalan, R., Khiste, S., Kulkarni, A., Kurmi, K., Mondal, J., Majumder, P. K., Bardia, A., Jang, H. L., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-021-01000-4 · Cited by 418
Autophagy Sustains Mitochondrial Glutamine Metabolism and Growth of Braf V600E–Driven Lung Tumors
Strohecker, A. M., Guo, J. Y., Karsli-Uzunbas, G., Price, S. M., Chen, G. J., Mathew, R., McMahon, M., & White, E. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0397 · Cited by 435
Signal pathways of melanoma and targeted therapy
Guo, W., Wang, H., & Li, C. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00827-6 · Cited by 379
“The suppression of PDH and relevant mitochondrial function is capable of abrogating BRAF-induced senescence, thereby licensing BRAF-driven melanoma development.(211) Therefore, mitochondrial function switches from tumor suppressor to oncogenic factor during melanoma carcinogenesis and development.”
BackgroundStacpoole, P. W. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx071 · Cited by 402
Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place
Kotsantis, P., Petermann, E., & Boulton, S. J. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1461 · Cited by 416
Li, T., Zhang, Z., Kolwicz, S. C., Abell, L., Roe, N. D., Kim, M., Zhou, B., Cao, Y., Ritterhoff, J., Gu, H., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.11.005 · Cited by 401
“It has been well documented that the PDH activity is rapidly regulated by reversible phosphorylation of its E1a component (Holness and Sugden, 2003; Kaplon et al., 2013; Kolobova et al., 2001).”
Mitochondria in Cell Senescence: Is Mitophagy the Weakest Link?
Korolchuk, V. I., Miwa, S., Carroll, B., & von Zglinicki, T. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.020 · Cited by 409
“The resulting combined activation of PDH enhanced the use of pyruvate in the tricarboxylic acid cycle, causing increased respiration and redox stress (Kaplon et al., 2013).”
BackgroundSenNet recommendations for detecting senescent cells in different tissues
Suryadevara, V., Hudgins, A. D., Rajesh, A., Pappalardo, A., Karpova, A., Dey, A. K., Hertzel, A., Agudelo, A., Rocha, A., Soygur, B., et al. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00738-8 · Cited by 408
Senescence-associated inflammatory responses: aging and cancer perspectives
Lasry, A., & Ben-Neriah, Y. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.009 · Cited by 408
Mitochondria as biosynthetic factories for cancer proliferation
Ahn, C. S., & Metallo, C. M. (2015) · Cancer & Metabolism · doi:10.1186/s40170-015-0128-2 · Cited by 399
“Suppression of PDK1 to activate PDH flux also contributes to BRAF(V600E)-induced oncogene senescence [27], further suggesting that limiting glucose oxidation is im-”
BackgroundMechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395
“Accordingly, a metabolic shift from glycolysis towards mitochondrial oxidative respiration through activation of mitochondrial pyruvate dehydrogenase is required to establish and stabilize the OIS-associated cell growth arrest [209].”
BackgroundSimilarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Andrejeva, G., & Rathmell, J. C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.004 · Cited by 373
Lin28 Enhances Tissue Repair by Reprogramming Cellular Metabolism
Shyh-Chang, N., Zhu, H., Yvanka de Soysa, T., Shinoda, G., Seligson, M. T., Tsanov, K. M., Nguyen, L., Asara, J. M., Cantley, L. C., & Daley, G. Q. (2013) · Cell · doi:10.1016/j.cell.2013.09.059 · Cited by 363
“Lin28a is therefore likely to be inducing senescence in vitro after passaging through oxidative stress (Miyauchi et al., 2004; Nogueira et al., 2008; Kaplon et al., 2013).”
Mitochondrial effectors of cellular senescence: beyond the free radical theory of aging
Ziegler, D. V., Wiley, C. D., & Velarde, M. C. (2015) · Aging Cell · doi:10.1111/acel.12287 · Cited by 354
“tion and cellular respiration by overexpression of the mitochondrial enzyme pyruvate dehydrogenase (PDH) enhances BRAF oncogeneinduced senescence (Kaplon et al., 2013).”
BackgroundSchell, J. C., Olson, K. A., Jiang, L., Hawkins, A. J., Van Vranken, J. G., Xie, J., Egnatchik, R. A., Earl, E. G., DeBerardinis, R. J., & Rutter, J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.026 · Cited by 363
“This PDH regulatory mechanism is required for oncogeneinduced transformation and reversed in oncogene-induced senescence (Kaplon et al., 2013).”
BackgroundVizioli, M. G., Liu, T., Miller, K. N., Robertson, N. A., Gilroy, K., Lagnado, A. B., Perez-Garcia, A., Kiourtis, C., Dasgupta, N., Lei, X., et al. (2020) · Genes & Development · doi:10.1101/gad.331272.119 · Cited by 359
“Senescent cells are metabolically active but accumulate dysfunctional mitochondria resulting in increased mitochondrial mass, increased oxygen consumption, decreased efficiency of oxidative phosphorylation, decreased membrane potential, and increased levels of reactive oxygen species (ROS) (Passos et al. 2007; Moiseev…”
Skin Aging, Cellular Senescence and Natural Polyphenols
Csekes, E., & Račková, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312641 · Cited by 320
p16Ink4a-induced senescence of pancreatic beta cells enhances insulin secretion
Helman, A., Klochendler, A., Azazmeh, N., Gabai, Y., Horwitz, E., Anzi, S., Swisa, A., Condiotti, R., Granit, R. Z., Nevo, Y., et al. (2016) · Nature Medicine · doi:10.1038/nm.4054 · Cited by 351
Ogrodnik, M. (2021) · Aging Cell · doi:10.1111/acel.13338 · Cited by 349
Cellular senescence: all roads lead to mitochondria
Martini, H., & Passos, J. F. (2023) · The FEBS Journal · doi:10.1111/febs.16361 · Cited by 334
Tan, Z., Xie, N., Cui, H., Moellering, D. R., Abraham, E., Thannickal, V. J., & Liu, G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402469 · Cited by 322
“PDK1 is a key regulatory enzyme involved in glucose metabolism (22, 23).”
BackgroundInfluentialMitochondrial dysfunction and cell senescence: deciphering a complex relationship
Chapman, J., Fielder, E., & Passos, J. F. (2019) · FEBS Letters · doi:10.1002/1873-3468.13498 · Cited by 325
Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities
Kerr, E. M., Gaude, E., Turrell, F. K., Frezza, C., & Martins, C. P. (2016) · Nature · doi:10.1038/nature16967 · Cited by 313
“Enhanced pyruvate dehydrogenase (Pdh) activity 19 could explain the glucose metabolism reprogramming exhibited by homozygous cells.”
Parmenter, T. J., Kleinschmidt, M., Kinross, K. M., Bond, S. T., Li, J., Kaadige, M. R., Rao, A., Sheppard, K. E., Hugo, W., Pupo, G. M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0440 · Cited by 283
Yang, Z., Wang, Y., Zhang, Y., He, X., Zhong, C.-Q., Ni, H., Chen, X., Liang, Y., Wu, J., Zhao, S., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-017-0022-y · Cited by 285
“Based on published studies 27,41 , the ratio of labelled [ 13 C 2 ]citrate (emulating PDC product) to [ 13 C 3 ] pyruvate (PDC substrate) in [U-13 C] glucose labelling experiment can be used to indicate intracellular PDC activity.”
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
Zhang, G., Frederick, D. T., Wu, L., Wei, Z., Krepler, C., Srinivasan, S., Chae, Y. C., Xu, X., Choi, H., Dimwamwa, E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82661 · Cited by 286
Sirtuins: guardians of mammalian healthspan
Giblin, W., Skinner, M. E., & Lombard, D. B. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.04.007 · Cited by 282
Fumarate induces redox-dependent senescence by modifying glutathione metabolism
Zheng, L., Cardaci, S., Jerby, L., MacKenzie, E. D., Sciacovelli, M., Johnson, T. I., Gaude, E., King, A., Leach, J. D. G., Edrada-Ebel, R., et al. (2015) · Nature Communications · doi:10.1038/ncomms7001 · Cited by 281
“Other examples include the loss of the tumour suppressors VHL and PTEN 2324 as well as the activation of the oncogenes Ras or BRAF 25,26,27 .”
Self-citationAging Hallmarks and Progression and Age-Related Diseases: A Landscape View of Research Advancement
Tenchov, R., Sasso, J. M., Wang, X., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00531 · Cited by 276
The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in Melanoma
Sheppard, K. E., & McArthur, G. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0259 · Cited by 265
“In cell line models, including melanocytes, manipulating p53, cytokines, cellular metabolism, or the phosphoinositide 3 kinase (PI3K) pathway (69, 76) has been shown to reverse the senescent phenotype.”
BackgroundThe Influence of Metabolism on Drug Response in Cancer
Zaal, E. A., & Berkers, C. R. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00500 · Cited by 272
Melanocytic nevi and melanoma: unraveling a complex relationship
Damsky, W. E., & Bosenberg, M. (2017) · Oncogene · doi:10.1038/onc.2017.189 · Cited by 248
The Warburg effect: a signature of mitochondrial overload
Wang, Y., & Patti, G. J. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.03.013 · Cited by 235
Mitochondrial Homeostasis and Cellular Senescence
Vasileiou, P., Evangelou, K., Vlasis, K., Fildisis, G., Panayiotidis, M., Chronopoulos, E., Passias, P.-G., Kouloukoussa, M., Gorgoulis, V., & Havaki, S. (2019) · Cells · doi:10.3390/cells8070686 · Cited by 244
“, increased mitochondrial oxidative metabolism) which characterizes cellular senescence, occurs in parallel with enhanced mitochondrial biogenesis [11,169].”
BackgroundCárdenas, C., Müller, M., McNeal, A., Lovy, A., Jaňa, F., Bustos, G., Urra, F., Smith, N., Molgó, J., Diehl, J. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.030 · Cited by 247
Mitochondria in the signaling pathways that control longevity and health span
Akbari, M., Kirkwood, T. B. L., & Bohr, V. A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100940 · Cited by 230
Phosphorylation of PDHA by AMPK Drives TCA Cycle to Promote Cancer Metastasis
Cai, Z., Li, C.-F., Han, F., Liu, C., Zhang, A., Hsu, C.-C., Peng, D., Zhang, X., Jin, G., Rezaeian, A.-H., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.09.018 · Cited by 227
“PDHc is a rate-limiting enzyme directly controlling pyruvate influx for the maintenance of TCA cycle, but its function in cancer progression is still under debate (Chen et al., 2018; Kaplon et al., 2013).”
James, E. L., Michalek, R. D., Pitiyage, G. N., de Castro, A. M., Vignola, K. S., Jones, J., Mohney, R. P., Karoly, E. D., Prime, S. S., & Parkinson, E. K. (2015) · Journal of Proteome Research · doi:10.1021/pr501221g · Cited by 231
Saunier, E., Benelli, C., & Bortoli, S. (2016) · International Journal of Cancer · doi:10.1002/ijc.29564 · Cited by 219
“Another oncogene, BRAF, which commonly is mutated in melanoma and other cancers, also has been found to modulate PDK1 expression and, thus, to influence tumor initiation, maintenance and progression.(26) More recently, PDK1 was identified as an important direct target of the Wnt signaling pathway within a larger gene…”
BackgroundDichloroacetate and cancer: New home for an orphan drug?
Kankotia, S., & Stacpoole, P. W. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.08.005 · Cited by 210
Pathways and therapeutic targets in melanoma
Shtivelman, E., Davies, M. A., Hwu, P., Yang, J., Lotem, M., Oren, M., Flaherty, K. T., & Fisher, D. E. (2014) · Oncotarget · doi:10.18632/oncotarget.1892 · Cited by 217
Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming
Chae, Y. C., Vaira, V., Caino, M. C., Tang, H.-Y., Seo, J. H., Kossenkov, A. V., Ottobrini, L., Martelli, C., Lucignani, G., Bertolini, I., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.004 · Cited by 209
“However, there is evidence that this pathway may extend well beyond bioenergetics, as PDK1 signaling has been implicated in senescence (Kaplon et al., 2013), metastatic tropism (Dupuy et al.”
BackgroundLow abundance of the matrix arm of complex I in mitochondria predicts longevity in mice
Miwa, S., Jow, H., Baty, K., Johnson, A., Czapiewski, R., Saretzki, G., Treumann, A., & von Zglinicki, T. (2014) · Nature Communications · doi:10.1038/ncomms4837 · Cited by 206
“Moreover, unbalanced complex I assembly might cause premature cellular senescence by either increased ROS production inducing DNA damage including premature telomere shortening 50-52 , by changed energy metabolism 53 , or both.”
Cellular senescence in cancer: from mechanisms to detection
Ou, H., Hoffmann, R., González‐López, C., Doherty, G. J., Korkola, J. E., & Muñoz‐Espín, D. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12807 · Cited by 190
Telomeres, oxidative stress and inflammatory factors: partners in cellular senescence?
Correia-Melo, C., Hewitt, G., & Passos, J. F. (2014) · Longevity & Healthspan · doi:10.1186/2046-2395-3-1 · Cited by 194
“RAS [58], BRAFV600E [59], p53 [60], p21 [61] and p16 [62] all resulted in elevated ROS generation.”
BackgroundInfluentialChen, J., Guccini, I., Di Mitri, D., Brina, D., Revandkar, A., Sarti, M., Pasquini, E., Alajati, A., Pinton, S., Losa, M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-017-0026-3 · Cited by 194
PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy
Dou, X., Fu, Q., Long, Q., Liu, S., Zou, Y., Fu, D., Xu, Q., Jiang, Z., Ren, X., Zhang, G., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00912-w · Cited by 183
“…during cellular senescence was observed, to date relevant data mostly derived from cancers such as lymphomas and melanomas, or senescent cells induced by activation of oncogenes (OIS) such as BRAF V600E , with the metabolic signaling axis specifically elucidated in senescent cancer cells 19,20 .”
Senescence as a therapeutic target in cancer and age-related diseases
McHugh, D., Durán, I., & Gil, J. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01074-4 · Cited by 197
Senescent Cells: Emerging Targets for Human Aging and Age-Related Diseases
Song, S., Lam, E. W.-F., Tchkonia, T., Kirkland, J. L., & Sun, Y. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.03.008 · Cited by 195
“Upon cellular senescence, mitochondria are less functional, with reduced membrane potential, increased proton leak, enhanced enzyme release, elevated mass, and more tricarboxylic acid (TCA) cycle metabolites [46,47].”
BackgroundGeneration of a p16 Reporter Mouse and Its Use to Characterize and Target p16high Cells In Vivo
Omori, S., Wang, T.-W., Johmura, Y., Kanai, T., Nakano, Y., Kido, T., Susaki, E. A., Nakajima, T., Shichino, S., Ueha, S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.09.006 · Cited by 194
Cellular Senescence in Postmitotic Cells: Beyond Growth Arrest
Sapieha, P., & Mallette, F. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.03.003 · Cited by 193
Corazao-Rozas, P., Guerreschi, P., Jendoubi, M., André, F., Jonneaux, A., Scalbert, C., Garçon, G., Malet-Martino, M., Balayssac, S., Rocchi, S., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1420 · Cited by 178
“This is consistent with the observation that the enforced expression of oncogenic BRAFV600E in fibroblasts is sufficient to promote mitochondrial oxidative metabolism characterized by high level of pyruvate oxidation, respiration and rise in oxidative stress [17].”
Stuart, S. D., Schauble, A., Gupta, S., Kennedy, A. D., Keppler, B. R., Bingham, P. M., & Zachar, Z. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-4 · Cited by 183
“For example, the pyruvate dehydrogenase (PDH) regulatory kinases (PDKs 1 to 4), negative regulators of the PDH complex, are up-regulated in many cancers, apparently to control anabolic flux and to modulate mitochondrial O2 consumption in the hypoxic tumor environment [14-17].”
Exploiting the bad eating habits of Ras-driven cancers
White, E. (2013) · Genes & Development · doi:10.1101/gad.228122.113 · Cited by 179
Senescence-Associated β-Galactosidase Detection in Pathology
Valieva, Y., Ivanova, E., Fayzullin, A., Kurkov, A., & Igrunkova, A. (2022) · Diagnostics · doi:10.3390/diagnostics12102309 · Cited by 182
“Such cells are no longer able to enter mitosis, therefore, tumor growth stops due to the accumulation of extensive and irreversible damage to telomeric and/or non-telomeric DNA (Figure 2) [20].”
BackgroundAging-Induced Stem Cell Mutations as Drivers for Disease and Cancer
Adams, P. D., Jasper, H., & Rudolph, K. L. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.05.002 · Cited by 180
“In addition, there is emerging evidence that oncogene-induced senescence can increase the rate of glucose metabolism both in glycolytic and in oxidative pathways (Dörr et al., 2013; Kaplon et al., 2013).”
BackgroundMetabolic rewiring in melanoma
Ratnikov, B. I., Scott, D. A., Osterman, A. L., Smith, J. W., & Ronai, Z. A. (2017) · Oncogene · doi:10.1038/onc.2016.198 · Cited by 171
Mitochondrial mass governs the extent of human T cell senescence
Callender, L. A., Carroll, E. C., Bober, E. A., Akbar, A. N., Solito, E., & Henson, S. M. (2020) · Aging Cell · doi:10.1111/acel.13067 · Cited by 169
“However, the overexpression of mitochondrial enzymes in yeast increases lifespan and caloric restriction (Kaplon et al., 2013), a well-established process to increase lifespan, and mediates its effects through improved mitochondrial activity.”
BackgroundRegulation of Survival Networks in Senescent Cells: From Mechanisms to Interventions
Soto-Gamez, A., Quax, W. J., & Demaria, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.05.036 · Cited by 175
“Accordingly, increased respiration and oxidative stress are crucial mediators of oncogene-induced senescence, and rely on the mitochondrial gatekeeper pyruvate dehydrogenase for enabling the use of pyruvate in the tricarboxylic acid cycle [85].”
BackgroundMitochondria, telomeres and cell senescence: Implications for lung ageing and disease
Birch, J., Barnes, P. J., & Passos, J. F. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.005 · Cited by 170
“In OIS, pyruvate dehydrogenase (PDH) kinase 1 is suppressed, leading to increased activity of PDH and enhanced usage of pyruvate in the TCA cycle (Kaplon et al., 2013).”
BackgroundLai, P., Liu, L., Bancaro, N., Troiani, M., Calì, B., Li, Y., Chen, J., Singh, P. K., Arzola, R. A., Attanasio, G., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.03.005 · Cited by 174
Where Metabolism Meets Senescence: Focus on Endothelial Cells
Sabbatinelli, J., Prattichizzo, F., Olivieri, F., Procopio, A. D., Rippo, M. R., & Giuliani, A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01523 · Cited by 167
Phenotype Switching in Melanoma: Implications for Progression and Therapy
Li, F. Z., Dhillon, A. S., Anderson, R. L., McArthur, G., & Ferrao, P. T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00031 · Cited by 163
“Studies have revealed that the adaptation can involve various phenotype changes including EMT-like processes, altered glycolytic activity (70) and ER stress response-activated cytoprotective autophagy (71).”
BackgroundPKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth
Morita, M., Sato, T., Nomura, M., Sakamoto, Y., Inoue, Y., Tanaka, R., Ito, S., Kurosawa, K., Yamaguchi, K., Sugiura, Y., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.02.004 · Cited by 171
Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies
Lucas, V., Cavadas, C., & Aveleira, C. A. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000622 · Cited by 160
Yin, Y., Choi, S.-C., Xu, Z., Zeumer, L., Kanda, N., Croker, B. P., & Morel, L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501537 · Cited by 172
“The resulting effect of DCA is to favor the oxidation of pyruvate to the expense of its conversion to lactate (27, 28).”
BackgroundKetone bodies mimic the life span extending properties of caloric restriction
Veech, R. L., Bradshaw, P. C., Clarke, K., Curtis, W., Pawlosky, R., & King, M. T. (2017) · IUBMB Life · doi:10.1002/iub.1627 · Cited by 169
“Consistent with it playing a role in the aging process, the PDH complex has also been shown to regulate cellular senescence (58).”
BackgroundOncogene-Directed Alterations in Cancer Cell Metabolism
Nagarajan, A., Malvi, P., & Wajapeyee, N. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.06.002 · Cited by 169
“Pyruvate dehydrogenase (PDH) is a mediator of BRAFV600E-induced senescence [39], which is accompanied by suppression of pyruvate dehydrogenase kinase 1 (PDK1; PDH-inhibitory enzyme) and induction of pyruvate dehydrogenase phosphatase 2 (PDP2; PDH-activating enzyme).”
BackgroundTargeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy
Anwar, S., Shamsi, A., Mohammad, T., Islam, A., & Hassan, M. I. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188568 · Cited by 161
Metadata
- Authors
- Kaplon, J., Zheng, L., Meissl, K., Chaneton, B., Selivanov, V. A., Mackay, G., van der Burg, S. H., Verdegaal, E. M. E., Cascante, M., Shlomi, T., Gottlieb, E., & Peeper, D. S.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Cancer Research UK Scotland Institute (GB)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Gottlieb, Eyal
- Peeper, Daniel S.
- ORCID
- Venue
- Nature
- Published
- 2013-05-19
- Volume
- 498
- Issue
- 7452
- Pages
- 109-112
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2164524616
- Cited by
- 633
- References
- 33
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 38 · 2023: 49 · 2022: 51 · 2021: 55 · 2020: 47 · 2019: 43 · 2018: 38 · 2017: 58 · 2016: 59 · 2015: 56 · 2014: 56 · 2013: 18
- FWCI
- 43.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- Cancer Research UK
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- oncogene-induced senescence, pyruvate dehydrogenase, pyruvate dehydrogenase kinase 1, PDP2, BRAF V600E mutation, melanoma, glucose oxidation, glycolysis, oxidative phosphorylation, mitochondrial metabolism, senescence-associated secretory phenotype, senescence-associated heterochromatin foci, senescence-associated DNA damage
- MeSH terms
- Pyruvate Dehydrogenase Acetyl-Transferring Kinase, Animals, Cell Line, Citric Acid Cycle, Disease Models, Animal, Enzyme Activation, Glycolysis, Humans, Melanoma, Mitochondria, Oncogenes, Oxidative Phosphorylation, Pyruvate Dehydrogenase Complex, Pyruvate Dehydrogenase (Lipoamide)-Phosphatase, Signal Transduction, Mice, SCID, Mice, Inbred NOD, Cellular Senescence, Protein Serine-Threonine Kinases, Proto-Oncogene Proteins B-raf, Mice, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.